drugset / Trial / NCT00148252

Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant

NCT00148252

Phase 4 Terminated 298 enrolled University of Oslo School of Pharmacy
RandomizedParallel-groupOpen-labelPrevention

Summary

To compare the change in renal function between CsA or MMF withdrawal from before to 12 months after drug withdrawal in renal transplant recipients on triple immunosuppressive therapy

Timeline

Start
2003-02
Primary completion
2005-11
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide
Subject Mycophenolate Mofetil Small molecule 2 g

Indications

No indication recorded.